Nov 26, 2019Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha RaAlpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Sep 5, 2018Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure CancerProceeds to accelerate expansion of global clinical research program and establish new production facilities to meet growing demand for...
Jul 15, 2018CEO Uzi Sofer Reveals Great News on Galatz Radio 02.07.2018Alpha Tau Medical focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for...
Sep 20, 2017May the New Year Begin- Happy Rosh HaShana!After an exiting year of significant progress in research and development, Uzi Sofer invited the whole team to his house in Jerusalem....